v3.26.1
Investments (Tables)
12 Months Ended
Dec. 31, 2025
Investments [Abstract]  
Summary of Marketable Equity Securities Marketable equity securities as of December 31, 2025 and December 31, 2024 are as follows:

 

 

Cost

 

 

Cost of Shares Sold

 

 

Gross Unrealized Gain

 

 

Fair Value

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 Marketable equity securities, December 31, 2025

 

$

27,050

 

 

$

-

 

 

$

10,330

 

 

$

37,380

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 Marketable equity securities, December 31, 2024

 

$

17,860

 

 

$

-

 

 

$

9,190

 

 

$

27,050

 

Schedule of Rollforward of Loan Activity

A rollforward of loan activity is as follows:

 

 

December 31, 2025

 

 

 

 

December 31, 2024

 

 

 

 

 

 

 

 

 

 Notes receivable from Tech Infrastructure JV I LLC

 

-

 

 

 

 

$

-

 

 

 

 

 

 

 

 

 

December 31, 2025

 

 

 

 

December 31, 2024

 

 

 

 

 

 

 

 

 

 Beginning of year

$

-

 

 

 

 

$

-

 

 Borrowings

 

-

 

 

 

 

 

3,587,195

 

 Accrued interest income

 

-

 

 

 

 

 

188,536

 

 Reclassification to fixed assets

 

-

 

 

 

 

 

(3,775,731

)

  End of period

$

-

 

 

 

 

$

-

 

Schedule of Long-term Investment - Equity Securities

Long-term investments for the SMHC warrants consist of the following:

 

December 31, 2025

 

 

 

 

December 31, 2024

 

 

 

 

 

 

 

 

 

 Seastar Medical Holding Corporation warrants

$

233

 

 

 

 

$

4,255

 

 End of period

$

233

 

 

 

 

$

4,255

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

December 31, 2025

 

 

 

 

December 31, 2024

 

 

 

 

 

 

 

 

 

 Beginning of year

$

4,255

 

 

 

 

$

156,992

 

 Unrealized loss on equity securities

 

(4,022

)

 

 

 

 

(152,737

)

 End of period

$

233

 

 

 

 

$

4,255

 

Summary of Investment in Unconsolidated Affiliates

 

December 31, 2025

 

 

 

 

December 31, 2024

 

 

 

 

 

 

 

 

 

 Seastar Medical Holding Corporation common stock

$

24,840

 

 

 

 

$

200,790

 

 End of period

$

24,840

 

 

 

 

$

200,790

 

 

 

 

 

 

 

 

 

 

December 31, 2025

 

 

 

 

December 31, 2024

 

 

 

 

 

 

 

 

 

 Beginning of year

$

200,790

 

 

 

 

$

1,145,486

 

 Unrealized loss on equity investment

 

(175,950

)

 

 

 

 

(944,696

)

 End of period

$

24,840

 

 

 

 

$

200,790